For reference: TFC · GGPeps · Poland.
I would like the axes of comparison first and the recommendation second.
I have tried the first option and it works; the question is whether the second is better rather than merely different.
Is there a defensible reason to prefer one, or is this a coin flip?
The part that matters: a single member running three suppliers on one method is worth more than thirty members running one supplier each.
Lead time and lane behaviour are supplier properties too and are easier to compare than analytical ones, because they need no laboratory at all.
Put another way, content is the more discriminating measurement than purity for supplier comparison, because purity clusters tightly among competent suppliers and content does not.
Gradient slope, column chemistry and detection wavelength all affect the reported purity figure, which is why the method section is the part that makes results comparable.
Use a fixed documentation checklist rather than an impression.
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL BiochemThis is the question where methodology matters more than the conclusion.
Compare documentation on a fixed checklist rather than by impression: lot specificity, method section, chromatogram availability, quantified content, water and counter-ion figures, and whether the code is on the vial.
To compare properly: order the same compound at the same nominal strength from each supplier, submit all samples to the same laboratory in the same submission if possible, and ask for the same test set on each.
Inter-laboratory spread on identical peptide material is routinely half a per cent to a per cent by RP-HPLC, which is the noise floor for any cross-laboratory comparison.
Nothing here is medical advice, and research-use compounds are not approved for human use.
One laboratory, one method, one submission. Otherwise it is not a comparison.
edited 29 Jun 2026 by m_haraldsen — fixed an arithmetic slip in the third paragraph
The relevant point is that two competent laboratories disagree by half a per cent on identical material, which is larger than most of the differences people argue about.
Sample size matters. One order each is an anecdote about six vials; three orders each over a year is the beginning of a comparison.
Publish the method with the result. A comparison without the laboratory named and the submission dates given is not reproducible by anyone.
Compare content, not purity. Purity clusters and content does not.
The short version: same compound, same laboratory, same method, ideally same week — otherwise you are comparing laboratories rather than suppliers.
Submitting to different laboratories introduces a method difference that commonly exceeds the supplier difference. Gradient slope alone can move a reported purity figure by a per cent in either direction.
The ratings on this site are a community opinion average on a ten-point scale and are not reconciled with any other community's figures.
Comparisons drawn from different laboratories at different times are weaker evidence than most people treat them as.
Price per milligram of measured peptide, not per milligram of label claim.
Ratings on this site are ours alone and are deliberately not reconciled with anyone else's.
Cost per milligram of actual peptide is the honest price comparison, which means dividing by measured content rather than by label claim.
Content assay results across the published datasets vary considerably more between suppliers than purity does, which makes content the more discriminating axis.
No supplier on this site pays for its position, and the storefront links are marked nofollow and sponsored.
Name the laboratory and the dates or the comparison cannot be reproduced.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.